Colan Totte.Co.,Ltd. (7792) AI Stock Analysis

0 Followers

Colan Totte.Co.,Ltd.

(TSE/TYO:7792)

Select Model

Rating:71Outperform

Price Target:JPY 1,565.00▲(7.05% Upside)

Action:reiterated

Date:11/12/26

The company's excellent financial health and deeply undervalued status are the primary drivers of the score. Strong profitability and a debt-free balance sheet provide a solid foundation. However, bearish technical momentum and a recent decline in free cash flow present notable risks that weigh on the overall assessment.

Positive Factors

Strong Revenue GrowthRevenue has more than doubled across the reported period, demonstrating substantial commercial expansion and sustained demand for the company’s offerings. Continued top-line growth broadens the earnings base, supports operating leverage, and provides resources to reinforce products, channels, and market position over the next several quarters.

Negative Factors

Uneven Cash ConversionCash generation has not consistently matched reported earnings, and free cash flow has moved sharply between periods. This reduces the predictability of internally generated funds, complicates capital planning, and means strong accounting profitability may not translate evenly into cash available for investment or distributions.

Colan Totte.Co.,Ltd. (7792) vs. iShares MSCI Japan ETF (EWJ)

Market Cap: JPY 13.30B
Dividend Yield: 3.42%
Average Volume (3M): 15.22K
Price to Earnings (P/E): 8.8
Beta (1Y): 0.51
Revenue Growth: 30.12%
EPS Growth: 13.38%
Country: Japan
Employees: 104
Sector: General
Sector Strength: 55
Industry: Medical - Devices

Colan Totte.Co.,Ltd. Business Overview & Revenue Model

Company Description

Colan Totte Co., Ltd., established in Osaka, Japan, in 1997, operates as an international firm specializing in the development and global distribution of therapeutic devices under its proprietary Colantotte brand. The company's diverse product portfo...

Colan Totte.Co.,Ltd. Financial Statement Overview

Summary

Strong revenue growth and expanding EBIT margins are offset by a decline in free cash flow. The pristine, debt-free balance sheet provides excellent stability, but the mixed cash flow performance tempers the overall financial score.

Income Statement

82Very Positive

Balance Sheet

90Very Positive

Cash Flow

65Positive

Financial statement breakdown
Breakdown	TTM	Sep 2026	Sep 2025	Sep 2024	Sep 2023	Sep 2022
Income Statement
Total Revenue	8.02B	9.00B	6.92B	5.94B	5.41B	4.66B
Gross Profit	5.46B	6.30B	4.66B	3.97B	3.45B	3.04B
EBITDA	2.06B	2.35B	1.90B	1.57B	1.10B	1.02B
Net Income	1.35B	1.51B	1.33B	1.02B	645.02M	610.45M
Balance Sheet
Total Assets	7.18B	7.92B	6.74B	5.43B	4.91B	4.13B
Cash, Cash Equivalents and Short-Term Investments	2.11B	2.50B	2.18B	1.76B	1.79B	1.34B
Total Debt	8.05M	9.67M	12.90M	8.69M	1.27M	270.48M
Total Liabilities	1.62B	1.62B	1.57B	1.32B	1.64B	1.38B
Stockholders Equity	5.55B	6.30B	5.17B	4.11B	3.27B	2.75B
Cash Flow
Free Cash Flow	1.06B	730.15M	728.70M	357.26M	867.34M	75.48M
Operating Cash Flow	1.48B	1.19B	998.35M	883.77M	955.70M	148.09M
Investing Cash Flow	-471.40M	-487.70M	-303.40M	-736.91M	-83.80M	-80.38M
Financing Cash Flow	-654.18M	-383.00M	-272.18M	-180.15M	-410.10M	-274.23M

Colan Totte.Co.,Ltd. Technical Analysis

Technical Analysis SentimentPositive

Last Price1462.00

Price Trends

50DMA1447.91Positive

100DMA1426.80Positive

200DMA1412.11Positive

Market Momentum

MACD-4.74Negative

RSI54.76Neutral

STOCH64.61Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:7792, the sentiment is Positive. The current price of 1462.00 is above the 20-day moving average (MA) of 1444.35, above the 50-day MA of 1447.91, and above the 200-day MA of 1412.11, indicating a bullish trend. The MACD of -4.74 indicates Negative momentum. The RSI at 54.76 is Neutral, neither overbought nor oversold. The STOCH value of 64.61 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:7792.

Colan Totte.Co.,Ltd. Peers Comparison

Overall Rating

UnderperformOutperform

Sector (55)

Financial Indicators

JP:7792 against its peers
Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
JP:5187	74Outperform	JPY 10.02B	25.83	―	4.36%	3.38%	-52.61%
JP:7792	71Outperform	JPY 13.34B	8.80	―	3.42%	30.12%	13.38%
JP:6849	63Neutral	JPY 248.62B	20.53	―	2.11%	-0.18%	-33.38%
JP:6523	61Neutral	JPY 156.61B	10.86	8.71%	3.41%	2.74%	145.33%
Sector *	55Neutral	$6.65B	3.83	-15.92%	6.20%	10.91%	7.18%
JP:4549	50Neutral	JPY 74.18B	40.03	―	2.58%	3.92%	-52.01%
JP:7600	45Neutral	JPY 8.43B	-5.42	―	5.31%	-8.68%	-75.03%

* General Sector Average

Performance Comparison

JP:7792 and its peers over the selected period
Ticker	Company Name	Price	Change	% Change
JP:7792	Colan Totte.Co.,Ltd.	1462.00	22.30	1.55%
JP:6523	PHC Holdings Corp.	1230.00	311.93	33.98%
JP:4549	Eiken Chemical Co., Ltd.	2250.00	-71.60	-3.08%
JP:5187	Create Medic Co., Ltd.	1102.00	135.73	14.05%
JP:6849	Nihon Kohden Corporation	1516.50	-29.11	-1.88%
JP:7600	Japan Medical Dynamic Marketing, Inc.	320.00	-162.41	-33.67%

Colan Totte.Co.,Ltd. Corporate Events

Colan Totte Reports Higher Sales, Profits and Dividend

Nov 6, 2026

Colan Totte Co., Ltd. is listed on the Tokyo Stock Exchange, but the release does not provide details about its industry or primary products. For the fiscal year ended September 30, 2026, the company reported net sales of ¥9,001 million, up 30.1% yea...

Glossary

BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Nov 12, 2026

Colan Totte.Co.,Ltd. AI Stock Analysis